Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

()

No description provided.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

01/01/1970

Market Cap

N/A

Shares Outstanding

N/A

Weighted SO

N/A

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

Beta

N/A

Last Div

N/A

Range

N/A

Chg

N/A

Avg Vol

N/A

Mkt Cap

N/A

Exch

N/A

Country

N/A

Phone

N/A

DCF Diff

N/A

DCF

N/A

Div Yield

N/A

P/S

N/A

EV Multiple

N/A

P/FV

N/A

Div Yield %

N/A

P/E

N/A

PEG

N/A

Payout

N/A

Current Ratio

N/A

Quick Ratio

N/A

Cash Ratio

N/A

DSO

N/A

DIO

N/A

Op Cycle

N/A

DPO

N/A

CCC

N/A

Gross Margin

N/A

Op Margin

N/A

Pretax Margin

N/A

Net Margin

N/A

Eff Tax Rate

N/A

ROA

N/A

ROE

N/A

ROCE

N/A

NI/EBT

N/A

EBT/EBIT

N/A

EBIT/Rev

N/A

Debt Ratio

N/A

D/E

N/A

LT Debt/Cap

N/A

Total Debt/Cap

N/A

Int Coverage

N/A

CF/Debt

N/A

Equity Multi

N/A

Rec Turnover

N/A

Pay Turnover

N/A

Inv Turnover

N/A

FA Turnover

N/A

Asset Turnover

N/A

OCF/Share

N/A

FCF/Share

N/A

Cash/Share

N/A

OCF/Sales

N/A

FCF/OCF

N/A

CF Coverage

N/A

ST Coverage

N/A

CapEx Coverage

N/A

Div&CapEx Cov

N/A

P/BV

N/A

P/B

N/A

P/S

N/A

P/E

N/A

P/FCF

N/A

P/OCF

N/A

P/CF

N/A

PEG

N/A

P/S

N/A

EV Multiple

N/A

P/FV

N/A

DPS

N/A

Latest Headlines (EST)

GlobeNewswire Inc. May 09, 05:00 Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 11, 2025 GlobeNewswire Inc. Jan 20, 21:30 Publication relating to transparency notifications GlobeNewswire Inc. Jan 20, 21:30 Publication relative à des notifications de transparence GlobeNewswire Inc. Nov 19, 06:00 Invitation à assister à l'assemblée générale spéciale des actionnaires de la Société qui se tiendra le 19 décembre 2024 GlobeNewswire Inc. Nov 19, 06:00 Invitation to attend the special shareholders’ meeting of the Company to be held on December 19, 2024 GlobeNewswire Inc. Oct 25, 20:30 Publication relative à des notifications de transparence GlobeNewswire Inc. Oct 25, 20:30 Publication relating to transparency notifications GlobeNewswire Inc. Sep 27, 20:30 DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update GlobeNewswire Inc. Jul 01, 06:00 Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA GlobeNewswire Inc. Jul 01, 06:00 Nyxoah Soumet le Quatrième et Dernier Module de sa Demande d'Autorisation de Mise sur le Marché (PMA) de Genio® à la FDA GlobeNewswire Inc. May 31, 06:00 Nyxoah Annonce la Clôture de l’Offre et l’Exercice Partiel de l’Option d’Achat d’Actions Supplémentaires GlobeNewswire Inc. May 31, 06:00 Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares Benzinga Dec 11, 13:00 Analyst Expectations for Nyxoah's Future GlobeNewswire Inc. Dec 11, 01:30 Nyxoah Announces Real World Case Series Demonstrating Positive Results in Treating CCC Patients with Genio® GlobeNewswire Inc. Dec 11, 01:30 Nyxoah Annonce la Présentation d’une Série de Cas Démontrant des Résultats Positifs dans le Traitement des Patients atteints de CCC avec Genio® GlobeNewswire Inc. Dec 11, 01:30 Nyxoah Announces Real World Case Series Demonstrating Positive Results in Treating CCC Patients with Genio® GlobeNewswire Inc. Dec 11, 01:30 Nyxoah Annonce la Présentation d’une Série de Cas Démontrant des Résultats Positifs dans le Traitement des Patients atteints de CCC avec Genio® GlobeNewswire Inc. Dec 11, 01:30 Nyxoah Announces Real World Case Series Demonstrating Positive Results in Treating CCC Patients with Genio® GlobeNewswire Inc. Dec 11, 01:30 Nyxoah Annonce la Présentation d’une Série de Cas Démontrant des Résultats Positifs dans le Traitement des Patients atteints de CCC avec Genio® GlobeNewswire Inc. Dec 11, 01:30 Nyxoah Announces Real World Case Series Demonstrating Positive Results in Treating CCC Patients with Genio®

Revenue Product Segmentation